Phosphoserine aminotransferase 1 is associated to poor outcome on tamoxifen therapy in recurrent breast cancer.

MLA

De Marchi, Tommaso, et al. “Phosphoserine Aminotransferase 1 Is Associated to Poor Outcome on Tamoxifen Therapy in Recurrent Breast Cancer.” Scientific Reports, vol. 7, no. 1, May 2017, p. 2099. EBSCOhost, https://doi.org/10.1038/s41598-017-02296-w.

APA

De Marchi, T., Timmermans, M. A., Sieuwerts, A. M., Smid, M., Look, M. P., Grebenchtchikov, N., Sweep, F. C. G. J., Smits, J. G., Magdolen, V., van Deurzen, C. H. M., Foekens, J. A., Umar, A., & Martens, J. W. (2017). Phosphoserine aminotransferase 1 is associated to poor outcome on tamoxifen therapy in recurrent breast cancer. Scientific Reports, 7(1), 2099. https://doi.org/10.1038/s41598-017-02296-w

Chicago

De Marchi, Tommaso, Mieke A Timmermans, Anieta M Sieuwerts, Marcel Smid, Maxime P Look, Nicolai Grebenchtchikov, Fred C G J Sweep, et al. 2017. “Phosphoserine Aminotransferase 1 Is Associated to Poor Outcome on Tamoxifen Therapy in Recurrent Breast Cancer.” Scientific Reports 7 (1): 2099. doi:10.1038/s41598-017-02296-w.